According to the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes. This is slightly more than 11% of the total population.
A diabetic’s body does not produce enough insulin or none at all. Patients should regularly control the level of sugar in the blood. Traditionally, this is done with the help of glucometers, with which diabetics repeatedly prick their fingers in search of drops of blood. But over the past decade, technology like continuous glucose monitoring has been on the rise.
Abbott and Dexcom are the two most dominant players in the space. Both companies posted growth.
The technology is also being marketed by several health and wellness programs as many companies see benefits for those without diabetes.
CNBC spoke with Abbott and Dexcom about the technology inside CGMs and how they see it expanding.
Watch the video to learn more.
